Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)

Abdom Imaging. 2011 Aug;36(4):463-71. doi: 10.1007/s00261-011-9729-6.


Although the current literature is limited, available data suggest that (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) imaging improves the evaluation of patients with recurrent pancreatic carcinoma and cholangiocarcinoma. There is evidence that PET/CT is particularly useful in the setting of elevated tumor markers and negative or equivocal CT findings. This article reviews the nature of these carcinomas in the post-therapy setting and describes the strengths and limitations of PET/CT when used for monitoring recurrence.

Publication types

  • Review

MeSH terms

  • Carcinoma / diagnostic imaging
  • Cholangiocarcinoma / diagnostic imaging*
  • Fluorodeoxyglucose F18*
  • Humans
  • Multimodal Imaging / methods*
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Pancreatic Neoplasms / diagnostic imaging*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Tomography, X-Ray Computed*


  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18